Literature DB >> 8786977

Regional drug delivery I: permeability characteristics of the rat 6-day-old air pouch model of inflammation.

S W Martin1, A J Stevens, B S Brennan, M L Reis, L A Gifford, M Rowland, J B Houston.   

Abstract

PURPOSE: To determine the permeability characteristics of the rat air pouch model of inflammation using permeability extremes within which the NSAIDs S[+] ibuprofen, piroxicam and diclofenac could be evaluated.
METHODS: Permeability was calculated using concentration data obtained following intrapouch and intravenous administration of [3H]-water, [14C]-urea, [14C]-inulin and [125I]-albumin and compared to similar data obtained for the three NSAIDs.
RESULTS: Similar permeability values (5-6.5 ml hr-1) were obtained for the three NSAIDS which fell between the permeability extremes of the molecular weight markers [3H]-water (9.7 ml hr-1), [14C]-urea (6.8 ml hr-1), [14C]-inulin (1.0 ml hr-1) and [125I]-albumin (0.6 ml hr-1). Coadministration of equipotent anti-inflammatory doses of the NSAIDs did not affect local blood flow to the air pouch (as assessed by urea kinetics) but did reduced vascular permeability (as assessed by albumin flux into the pouch).
CONCLUSIONS: Comparison of the NSAIDs with the permeabilities of the molecular weight markers indicates that a perfusion rate limitation probably exists. Systemic absorption is complete over the first two hours following intrapouch administration of the NSAIDs, therefore albumin flux into the pouch is insufficient to materially affect the permeability of the NSAIDs. However, subsequently (post 5hr) albumin concentration in the pouch rises sufficiently to lower the effective flux of the NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786977     DOI: 10.1023/a:1016260426830

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Interstitial exclusion of albumin in rat tissues measured by a continuous infusion method.

Authors:  H Wiig; M DeCarlo; L Sibley; E M Renkin
Journal:  Am J Physiol       Date:  1992-10

2.  Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.

Authors:  C A Hunt; R D Macgregor; R A Siegel
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

3.  Regional drug delivery II: relationship between drug targeting index and pharmacokinetic parameters for three non-steroidal anti-inflammatory drugs using the rat air pouch model of inflammation.

Authors:  A J Stevens; S W Martin; B S Brennan; A McLachlan; L A Gifford; M Rowland; J B Houston
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

4.  Studies into the mode of action of non-steroidal anti-inflammatory drugs using a model of facsimile synovium.

Authors:  A D Sedgwick; Y M Sin; A R Mackay; A Al-Duaij; D A Willoughby
Journal:  J Pharm Pharmacol       Date:  1984-03       Impact factor: 3.765

Review 5.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

6.  Influence of administration route on drug delivery to a target organ.

Authors:  S Oie; J D Huang
Journal:  J Pharm Sci       Date:  1981-12       Impact factor: 3.534

7.  Permeability of dog erythrocytes to [14C]urea.

Authors:  R A Garrick; F P Chinard
Journal:  Microvasc Res       Date:  1980-07       Impact factor: 3.514

8.  Enhancement of inflammatory reactions in a non-immunological air pouch model in rats.

Authors:  M Isaji; Y Momose; J Naito
Journal:  Br J Exp Pathol       Date:  1989-12

9.  The six-day-old rat air pouch model of inflammation: characterization of the inflammatory response to carrageenan.

Authors:  S W Martin; A J Stevens; B S Brennan; D Davies; M Rowland; J B Houston
Journal:  J Pharmacol Toxicol Methods       Date:  1994-11       Impact factor: 1.950

10.  A pharmacological and histological examination of the microcirculation of the rat subcutaneous air-pouch: microcirculation of the rat air-pouch.

Authors:  T Takagi; M J Forrest; P M Brooks
Journal:  Pathology       Date:  1987-07       Impact factor: 5.306

View more
  7 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.

Authors:  A C Heatherington; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

3.  Regional drug delivery II: relationship between drug targeting index and pharmacokinetic parameters for three non-steroidal anti-inflammatory drugs using the rat air pouch model of inflammation.

Authors:  A J Stevens; S W Martin; B S Brennan; A McLachlan; L A Gifford; M Rowland; J B Houston
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

4.  Pharmacokinetic considerations of regional administration and drug targeting: influence of site of input in target tissue and flux of binding protein.

Authors:  M Rowland; A McLachlan
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

Review 5.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

6.  Expression of arachidonic acid-metabolizing cytochrome P450s in human megakaryocytic Dami cells.

Authors:  Yazun Bashir Jarrar; Jae-Gook Shin; Su-Jun Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-31       Impact factor: 2.416

7.  Intradermal air pouch leukocytosis as an in vivo test for nanoparticles.

Authors:  Jennifer Vandooren; Nele Berghmans; Chris Dillen; Ilse Van Aelst; Isabelle Ronsse; Liron Limor Israel; Ina Rosenberger; Jörg Kreuter; Jean-Paul Lellouche; Shulamit Michaeli; Erica Locatelli; Mauro Comes Franchini; Miren K Aiertza; Laura Sánchez-Abella; Iraida Loinaz; Dylan R Edwards; Louis Shenkman; Ghislain Opdenakker
Journal:  Int J Nanomedicine       Date:  2013-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.